About Functional Fluidics
Functional Fluidics is a company based in Detroit (United States) founded in 2013. Functional Fluidics has raised $3.58 million across 6 funding rounds from investors including HHS and NYBC Ventures. Functional Fluidics offers products and services including Flow Adhesion Assay, Dynamic Sickling Assay, and Mechanical Fragility Assay. Functional Fluidics operates in a competitive market with competitors including Quiver Bioscience, MaxWell Biosystems, Forcyte Biotechnologies, Novoheart and Multi Channel Systems, among others.
- Headquarter Detroit, United States
- SectorsHealthcare
- Phone•••• ••••
- Website functionalfluidics.com
- Social LinkedIn X Instagram YouTube
- Legal Name Functional Fluidics Inc.
- Total Equity Funding$3.58M (USD)
in 6 rounds
- Latest Funding Round$265.35K (USD), Grant
Sep 2024
- InvestorsHHS
& 1 more
Products & Services of Functional Fluidics
Functional Fluidics offers a comprehensive portfolio of products and services, including Flow Adhesion Assay, Dynamic Sickling Assay, and Mechanical Fragility Assay.
Evaluates red blood cell adhesion for sickle cell disease studies.
Assesses hemoglobin S polymerization in red blood cells.
Measures red blood cell durability under mechanical stress.
Apps and channels of Functional Fluidics
its YouTube channel Functional Fluidics has 18 subscribers and 11 videos.
Videos from Functional Fluidics
The most watched videos on Functional Fluidics's YouTube channel, Functional Fluidics (18 subscribers). Click a video to play it here.
More on Functional Fluidics.
Funding Insights of Functional Fluidics
Functional Fluidics has successfully raised a total of $3.58M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $265.35 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.58M
- Total Rounds 6
- Last Round Grant — $265,347
- First Round $224,312
(Mar 2019)
- Investors Count 2
All 6 funding rounds of Functional Fluidics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $265,347 | Grant | – | – | |
| Dec 2023 | – | Series A | – | NYBC Ventures | – |
| Jan 2021 | $3.43M | Series A | – | – | – |
| Sep 2020 | – | Grant | – | – | |
| May 2019 | $150,000 | Seed | – | – | – |
| Mar 2019 | $224,312 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Functional Fluidics
Functional Fluidics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NYBC Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | nybcventures.com | - | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Functional Fluidics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Functional Fluidics
4 people are tracked at Functional Fluidics (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Nnamdi Okeke | Vice President, Head Of Global and Scientific Affairs, Sickle Cell Disease | Leadership |
Aliya U. Zaidi, PhD | Director Of Contract Research | Leadership |
Patrick Hines | CEO & Founder | Leadership |
Gregorio M. | Laboratory Tech | Team |
Complete people profiles for Functional Fluidics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Functional Fluidics
3 dated milestones of Functional Fluidics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Functional Fluidics is founded.
- Funding First funding round of $224K.
- Funding Latest funding round, Grant, of $265K.
Competitors of Functional Fluidics
Functional Fluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quiver Bioscience, MaxWell Biosystems, Forcyte Biotechnologies, Novoheart and Multi Channel Systems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quiverbioscience.com | 2013 | Cambridge, United States | – | – | Developer of transformational medicines for neurological disorders | |
| mxwbio.com | 2016 | Basel, Switzerland | $4.64M | – | In vitro electrophysiology platform for electrogenic cell analysis is developed. | |
| forcytebio.com | 2017 | Los Angeles, United States | $1.13M | – | Automated single-cell contractility screening systems are developed for drug discovery. | |
| novoheart.com | 2014 | Vancouver, Canada | – | – | Bioartificial hearts are engineered using stem cells and tissue methods. | |
| multichannelsystems.com | 1996 | Reutlingen, Germany | – | 68 | Tools and systems for electrophysiology are developed and supplied. | |
| relitect.com | 2014 | Lanark, United Kingdom | $1.13M | – | Label-free biomolecule detection is enabled via electrochemical impedance sensors. | |
| sysmex-europe.com | 1980 | Norderstedt, Germany | – | – | Sysmex Europe offers diagnostic instruments and services for healthcare laboratories worldwide. | |
| cytocybernetics.com | 2013 | Buffalo, United States | – | – | Electrophysiology tools such as patch clamp systems are developed. | |
| nanion.de | 2002 | Munich, Germany | – | – | Automated patch clamp platforms for electrophysiology are developed. |
Detailed competitors of Functional Fluidics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Functional Fluidics
The website of Functional Fluidics (functionalfluidics.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 48.6% vs previous month
Similar companies to Functional Fluidics
10 companies that operate in the same segment as Functional Fluidics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Functional Fluidics
Functional Fluidics was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Functional Fluidics is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
Functional Fluidics is a funded company, having raised a total of $3.58M across 6 funding rounds to date. The company's 1st funding round was a Grant of $224.31K, raised on Mar 2019.
Developer of microfluidics-based assays to study blood disorders. The company uses microfluidic channels coated with various types of substrates and markers to simulate blood flow in vivo and then utilize high-end analytical methods to study the behavior of the cells under various controlled conditions. The assay paradigms include flow adhesion, whole blood thrombosis assays, flow adhesion dynamics, a reversal of flow adhesion, etc. The company currently offers its expertise to clients for drug discovery and companion diagnostics development for blood disorders such as sickle cell disease, and a wide range of clotting and bleeding defects.
Functional Fluidics's top competitors include Quiver Bioscience, Novoheart and Forcyte Biotechnologies.
Functional Fluidics offers Flow Adhesion Assay, Dynamic Sickling Assay, and Mechanical Fragility Assay.
Functional Fluidics has 2 investors. Key investors include HHS, and NYBC Ventures.
Functional Fluidics operates through Functional Fluidics Inc..